Myriad Genetics
MYGN
#6702
Rank
C$0.91 B
Marketcap
C$9.80
Share price
-3.27%
Change (1 day)
-53.44%
Change (1 year)

Myriad Genetics (MYGN) - Cash on Hand

Cash on Hand as of September 2025 : C$0.20 Billion

According to Myriad Genetics's latest financial reports the company has C$0.20 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Myriad Genetics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.14 B-21.37%
2023-12-31C$0.18 B19.86%
2022-12-31C$0.15 B-63.89%
2021-12-31C$0.43 B
2020-06-30C$0.29 B64.97%
2019-06-30C$0.17 B-24.54%
2018-06-30C$0.23 B21.31%
2017-06-30C$0.19 B-4.98%
2016-06-30C$0.20 B14.04%
2015-06-30C$0.18 B-9.17%
2014-06-30C$0.19 B-49.18%
2013-06-30C$0.39 B12.89%
2012-06-30C$0.34 B3.84%
2011-06-30C$0.33 B-21.78%
2010-06-30C$0.42 B17.26%
2009-06-30C$0.36 B8.72%
2008-06-30C$0.33 B47.54%
2007-06-30C$0.22 B-10.25%
2006-06-30C$0.25 B78.92%
2005-06-30C$0.14 B-8%
2004-06-30C$0.15 B56.71%
2003-06-30C$98.02 M-11.51%
2002-06-30C$0.11 B-42.52%
2001-06-30C$0.19 B61.47%
2000-06-30C$0.11 B718.73%
1999-06-30C$14.57 M-32.15%
1998-06-30C$21.48 M-0.9%
1997-06-30C$21.68 M20.47%
1996-06-30C$17.99 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Bio-Rad Laboratories
BIO
C$1.96 B 875.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
C$1.38 B 589.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C$9.17 M-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.04 B 916.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$10.69 B 5,218.43%๐Ÿ‡บ๐Ÿ‡ธ USA